SG10201609347RA - Cell Culture Medium Comprising Small Peptides - Google Patents

Cell Culture Medium Comprising Small Peptides

Info

Publication number
SG10201609347RA
SG10201609347RA SG10201609347RA SG10201609347RA SG10201609347RA SG 10201609347R A SG10201609347R A SG 10201609347RA SG 10201609347R A SG10201609347R A SG 10201609347RA SG 10201609347R A SG10201609347R A SG 10201609347RA SG 10201609347R A SG10201609347R A SG 10201609347RA
Authority
SG
Singapore
Prior art keywords
culture medium
cell culture
small peptides
peptides
small
Prior art date
Application number
SG10201609347RA
Other languages
English (en)
Inventor
Shawn Barrett
Scott Jacobia
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44816118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201609347R(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Publication of SG10201609347RA publication Critical patent/SG10201609347RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
SG10201609347RA 2010-04-23 2011-04-22 Cell Culture Medium Comprising Small Peptides SG10201609347RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32764410P 2010-04-23 2010-04-23
US13/092,016 US20110262965A1 (en) 2010-04-23 2011-04-21 Cell culture medium comprising small peptides

Publications (1)

Publication Number Publication Date
SG10201609347RA true SG10201609347RA (en) 2017-01-27

Family

ID=44816118

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10201609347RA SG10201609347RA (en) 2010-04-23 2011-04-22 Cell Culture Medium Comprising Small Peptides
SG2012077566A SG184936A1 (en) 2010-04-23 2011-04-22 Cell culture medium comprising small peptides
SG10201503196VA SG10201503196VA (en) 2010-04-23 2011-04-22 Cell Culture Medium Comprising Small Peptides

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG2012077566A SG184936A1 (en) 2010-04-23 2011-04-22 Cell culture medium comprising small peptides
SG10201503196VA SG10201503196VA (en) 2010-04-23 2011-04-22 Cell Culture Medium Comprising Small Peptides

Country Status (10)

Country Link
US (6) US20110262965A1 (fr)
EP (4) EP3168295B1 (fr)
JP (6) JP6016783B2 (fr)
KR (6) KR102109463B1 (fr)
CN (3) CN110205282A (fr)
AU (6) AU2011242496C1 (fr)
DE (1) DE202011110859U1 (fr)
DK (3) DK3165600T3 (fr)
SG (3) SG10201609347RA (fr)
WO (1) WO2011133902A2 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
US20130130317A1 (en) * 2010-08-02 2013-05-23 Kyowa Hakko Kirin Co., Ltd Method for producing substance
SG187198A1 (en) 2010-08-05 2013-03-28 Amgen Inc Dipeptides to enhance yield and viability from cell cultures
EP2702077A2 (fr) 2011-04-27 2014-03-05 AbbVie Inc. Procédé de contrôle du profil de galactosylation de protéines exprimées de manière recombinante
CN102533634A (zh) * 2012-02-22 2012-07-04 江阴剑桥生物技术有限公司 Cho细胞无血清无蛋白化学培养基
EP2832848B1 (fr) 2012-03-30 2019-02-13 Ajinomoto Co., Inc. Milieu de culture pour faire proliférer une cellule souche, qui contient un composé sulfaté
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (fr) 2012-04-20 2013-10-24 Abbvie Inc. Procédés de modulation de la distribution de variant de lysine c-terminal
CA3051089C (fr) 2012-05-02 2022-04-12 Life Technologies Corporation Expression transitoire a haut rendement dans des cellules de mammifere a l'aide d'un appariement unique d'un milieu de croissance et de transfection a haute densite et d'activateu rs d'expression
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (fr) 2013-03-14 2014-09-25 Abbvie Inc. Procédés pour la modulation des profils de glycosylation de protéines de traitements à base de protéines recombinantes au moyen de monosaccharides et d'oligosaccharides
JP6190205B2 (ja) * 2013-08-08 2017-08-30 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株、その製造方法及び培地
JP6195191B2 (ja) * 2013-08-08 2017-09-13 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株を用いた組換えタンパク質の製造方法
EP3052640A2 (fr) * 2013-10-04 2016-08-10 AbbVie Inc. Utilisation d'ions métaux pour la modulation des profils de glycosylation de protéines recombinantes
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
CN104593318B (zh) * 2013-10-31 2018-05-04 中国食品发酵工业研究院 一种用于细胞培养基的玉米活性肽添加剂
US9534026B2 (en) * 2013-10-31 2017-01-03 China National Research Institute Of Food & Fermentation Industries Corn active peptide additive for cell culture medium
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
CA2945390A1 (fr) 2014-04-10 2015-10-15 Bayer Healthcare Llc Formulation de poudre de milieux melanges et procede de preparation de milieu liquide pour la culture cellulaire
WO2015175672A1 (fr) * 2014-05-14 2015-11-19 Merial, Inc. Procédés de lyophilisation et de réhydratation de produits biologiques
SG10201811177SA (en) 2014-06-18 2019-01-30 Medimmune Llc Cell culture methods and media comprising n-acetylcysteine
CN106661557B (zh) * 2014-08-11 2022-01-18 豪夫迈·罗氏有限公司 用于增加真核细胞的比生产率的方法
EP3303555B1 (fr) * 2015-05-29 2020-06-24 Merck Patent GmbH Solvants eutectiques profonds et/ou liquides ioniques dans des milieux de cultures cellulaires
CA3000926A1 (fr) * 2015-11-02 2017-05-11 Ares Trading S.A. Methodes de modulation de profils de production de proteines de recombinaison en mode perfusion
SG11201806335RA (en) * 2016-02-22 2018-09-27 Agency Science Tech & Res Cell culture medium
CN107760651A (zh) * 2016-08-23 2018-03-06 四川科伦博泰生物医药股份有限公司 一种细胞培养基及生产蛋白质的方法
DK3372670T3 (da) * 2017-03-09 2019-05-20 Evonik Technochemie Gmbh Dyrkningsmedier, der omfatter n-acyl-x-glutamindipeptider
ES2901134T3 (es) 2017-03-09 2022-03-21 Evonik Operations Gmbh Medio de cultivo que comprende oligopéptidos
DE102017203908B3 (de) * 2017-03-09 2018-05-30 Evonik Technochemie Gmbh Kulturmedium, umfassend Oligopeptide
WO2018181342A1 (fr) * 2017-03-28 2018-10-04 味の素株式会社 Additif pour milieu de maintien de dédifférenciation
CN106978390B (zh) * 2017-05-22 2020-11-13 广东顺德工业设计研究院(广东顺德创新设计研究院) 适用于贴壁型cho细胞的无血清培养基及培养方法
CN107278892A (zh) * 2017-06-26 2017-10-24 浦江县美泽生物科技有限公司 紫玉兰的高效组织培养方法
CA3078759A1 (fr) * 2017-10-13 2019-04-18 Boehringer Ingelheim International Gmbh Milieu de perfusion
US20210171901A1 (en) * 2017-11-16 2021-06-10 Life Technologies Corporation Streamlined methods for making liquid media
KR20200100108A (ko) * 2017-12-20 2020-08-25 바스프 에스이 양친매성 그라프트 공중합체를 세포 배양 시약으로 이용하여 세포 배양 시스템을 안정화하는 방법
CN112352046A (zh) * 2018-06-29 2021-02-09 长濑产业株式会社 麦角硫因、抗坏血酸2-葡糖苷、抗坏血酸和它们的组合的成肌分化促进作用
JP7197339B2 (ja) * 2018-12-05 2022-12-27 アサヒグループ食品株式会社 コク味付与物質含有酵母の製造方法及びコク味付与物質含有酵母エキスの製造方法
CN109628378B (zh) * 2019-01-25 2020-07-17 江苏丰华生物制药有限公司 一种利用花生蛋白酶解物培养cho细胞的方法
DK4138771T3 (da) 2020-04-20 2024-05-27 Evonik Operations Gmbh Sammensætninger, som omfatter cys-peptidr
GB202012991D0 (en) 2020-08-20 2020-10-07 Ucb Biopharma Sprl Cell culture processes
KR20240055110A (ko) * 2021-09-15 2024-04-26 에보닉 오퍼레이션스 게엠베하 디펩티드 및 미량 원소를 포함하는 조성물
KR20240073107A (ko) 2021-10-05 2024-05-24 에보닉 오퍼레이션스 게엠베하 디펩티드의 염 및 세포 배양에서의 이의 용도
WO2023165969A1 (fr) 2022-03-03 2023-09-07 Evonik Operations Gmbh Procédé pour améliorer la production de vecteurs viraux dans une culture cellulaire à l'aide de glycyl-glutamine
EP4302837A3 (fr) * 2022-05-12 2024-05-01 Evonik Operations GmbH Compositions photostabilisées et procédé de stabilisation de composants photosensibles
KR102609654B1 (ko) * 2023-03-23 2023-12-05 코스맥스 주식회사 인간 피부 유래 산물을 포함하는 미생물 배양 배지 및 이를 이용하여 배양된 혼합 미생물 배양액의 피부 개선 용도

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235772A (en) * 1978-06-21 1980-11-25 Ab Kabi Novel peptides having growth promoting activity
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
DE3206810C2 (de) 1982-02-25 1983-12-29 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen N ↑2↑-L-Tyrosinyl-N ↑6↑-L-tyrosinyl-L-lysin und N ↑2↑-L-Cystinyl-N ↑6↑-L-cystinyl-L-lysin, Verfahren zu deren Herstellung und deren Verwendung
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
KR900007085B1 (ko) * 1985-10-22 1990-09-28 플랜트 제네틱스, 인코포레이티드 체배형성을 증가시키는 방법 및 배지
DE3538310A1 (de) 1985-10-28 1987-04-30 Pfrimmer Pharma Verwendung von glutamin in form seiner di- und tripeptide im naehrmedium fuer zellkulturen
JPH01501706A (ja) 1986-10-24 1989-06-15 プリマー　カビ　ゲーエムベーハー　ウント　コ．カーゲー 経口投与及び腸管外投与用のｎ，ｎ′―ビス―ｌ―アミノ酸―ｌ―シスチン―ペプタイドを含有するアミノ酸製剤
US5206220A (en) 1990-04-23 1993-04-27 Research Corporation Technologies, Inc. Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
IE911351A1 (en) * 1990-04-23 1991-10-23 Res Corp Technologies Inc Soluble tyrosine and cysteine source for total parenteral¹nutrition
US5328844A (en) * 1990-05-09 1994-07-12 University Of Colorado Foundation, Inc. Culture media for mammalian cells
DE4022267C2 (de) 1990-07-12 1994-09-15 Degussa N-Acyldipeptide und deren Verwendung
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB2251249B (en) 1990-12-28 1995-06-21 Mogam Biotech Res Inst High-density medium for animal cell culture
AU703484B2 (en) * 1995-02-23 1999-03-25 Quest International Services B.V. Peptides for tissue and cell culture media
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
EP1482031B1 (fr) 1996-08-30 2015-10-28 Life Technologies Corporation Milieu de culture de cellules de mammifères exempt de sérum et son utilisation
US20030130195A1 (en) * 2000-01-27 2003-07-10 Universite Laval Enzymatic hydrolysate of milk proteins
US6759510B1 (en) 2000-06-30 2004-07-06 Becton, Dickinson And Company Peptides for use in culture media
WO2002050102A2 (fr) * 2000-12-20 2002-06-27 Novartis Ag Inhibiteurs de l'interaction e2f-1/cycline utiles pour la therapie anticancereuse
US20030096414A1 (en) 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
US20030232430A1 (en) * 2001-11-26 2003-12-18 Advanced Cell Technology Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
CA2478901A1 (fr) 2002-03-29 2003-10-16 Merck & Co., Inc. Procedes de production de virus
AU2003303394B2 (en) * 2002-12-23 2009-02-19 Bristol-Myers Squibb Company Product quality enhancement in mammalian cell culture processes for protein production
US7193038B2 (en) * 2003-02-28 2007-03-20 National Institute Of Agrobiological Sciences Extraction and utilization of cell growth-promoting peptides from silk protein
AU2004323200B2 (en) * 2003-12-11 2008-12-04 Clonex Development, Inc. Cell lines for use in increasing protein yield from a cell culture
US20050287666A1 (en) 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
EP1829968A4 (fr) 2004-12-20 2008-09-10 Ajinomoto Kk Proteine mutante presentant une activite de production de peptides
KR20090074040A (ko) * 2006-09-13 2009-07-03 아보트 러보러터리즈 세포 배양의 개선
MX2009002741A (es) 2006-09-15 2009-05-11 Medimmune Llc Lineas de celulas mdck que soportan el crecimiento viral para altos titulos y proceso de biorreactor que utiliza las mismas.
WO2008035631A1 (fr) * 2006-09-20 2008-03-27 Kyowa Hakko Kogyo Co., Ltd. Procédé de production d'une substance
ES2538986T3 (es) * 2006-11-08 2015-06-25 Wyeth Llc Medios diseñados racionalmente para un cultivo celular
KR101574355B1 (ko) 2007-04-26 2015-12-11 추가이 세이야쿠 가부시키가이샤 고농도 아미노산 함유 배지를 사용한 세포의 배양 방법
JP2008276843A (ja) 2007-04-27 2008-11-13 Hitachi Ltd レーザー駆動方法及び光ディスク記録再生装置
US8053236B2 (en) * 2007-05-11 2011-11-08 Amgen Inc. Feed media
JP2010535499A (ja) 2007-08-03 2010-11-25 キャンピナ・ネダーランド・ホールディング・ビー．ブイ． 真核細胞用の培地
JP4911523B2 (ja) * 2007-10-22 2012-04-04 国立大学法人群馬大学 温度応答性配列を含むデプシペプチド構造と親水性高分子構造からなるブロック共重合体
WO2009060620A1 (fr) * 2007-11-08 2009-05-14 Fujifilm Corporation Procédé pour produire un polypeptide
JP5270239B2 (ja) 2008-07-08 2013-08-21 不二製油株式会社 ペプチド性脂質低下剤
US8252557B2 (en) 2008-10-28 2012-08-28 Chugai Seiyaku Kabushiki Kaisha Peptide-containing culture medium for culturing animal cell
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
US20130130317A1 (en) * 2010-08-02 2013-05-23 Kyowa Hakko Kirin Co., Ltd Method for producing substance
SG187198A1 (en) * 2010-08-05 2013-03-28 Amgen Inc Dipeptides to enhance yield and viability from cell cultures

Also Published As

Publication number Publication date
AU2018202612B2 (en) 2020-10-29
KR102264580B1 (ko) 2021-06-11
EP3168295B1 (fr) 2022-11-02
CN110205282A (zh) 2019-09-06
AU2018202612A1 (en) 2018-05-10
KR102109463B1 (ko) 2020-05-12
US11365389B2 (en) 2022-06-21
KR101831549B1 (ko) 2018-02-22
KR20170051527A (ko) 2017-05-11
AU2021200418B2 (en) 2023-05-25
EP3165600B1 (fr) 2022-11-02
KR20130106762A (ko) 2013-09-30
JP6367293B2 (ja) 2018-08-01
KR20160138316A (ko) 2016-12-02
JP2017006127A (ja) 2017-01-12
JP7481407B2 (ja) 2024-05-10
KR20170089027A (ko) 2017-08-02
US20110262965A1 (en) 2011-10-27
US20200308537A1 (en) 2020-10-01
AU2016256736B2 (en) 2018-11-01
DK3168295T3 (da) 2022-11-21
US10793827B2 (en) 2020-10-06
WO2011133902A2 (fr) 2011-10-27
AU2011242496A1 (en) 2012-10-25
JP2022171839A (ja) 2022-11-11
KR101832795B1 (ko) 2018-02-28
US20170342371A1 (en) 2017-11-30
SG184936A1 (en) 2012-11-29
JP2018113996A (ja) 2018-07-26
JP7200180B2 (ja) 2023-01-06
EP4170016A1 (fr) 2023-04-26
JP6016783B2 (ja) 2016-10-26
AU2016200611A1 (en) 2016-02-18
SG10201503196VA (en) 2015-06-29
WO2011133902A3 (fr) 2012-04-19
JP2017060496A (ja) 2017-03-30
JP2013524817A (ja) 2013-06-20
US20230365919A1 (en) 2023-11-16
AU2018202222A1 (en) 2018-04-26
EP2561065B1 (fr) 2016-11-09
AU2021200418A1 (en) 2021-02-25
AU2011242496B2 (en) 2015-11-19
KR101733834B1 (ko) 2017-05-08
AU2011242496C1 (en) 2017-03-09
DE202011110859U1 (de) 2016-12-20
DK2561065T3 (en) 2017-02-13
EP2561065A4 (fr) 2013-07-03
US20170058256A1 (en) 2017-03-02
JP2020137529A (ja) 2020-09-03
CN106520658A (zh) 2017-03-22
EP2561065A2 (fr) 2013-02-27
DK3165600T3 (da) 2022-12-05
US20220275325A1 (en) 2022-09-01
EP3168295A1 (fr) 2017-05-17
CN102892878A (zh) 2013-01-23
KR20200051847A (ko) 2020-05-13
AU2016256736A1 (en) 2016-12-01
KR20180023019A (ko) 2018-03-06
EP3165600A1 (fr) 2017-05-10

Similar Documents

Publication Publication Date Title
SG10201503196VA (en) Cell Culture Medium Comprising Small Peptides
IL226971B (en) Cell culture medium
IL222452A0 (en) Improved cell culture medium
IL222453A0 (en) Improved cell culture medium
EP2582788A4 (fr) Milieu de culture cellulaire à composition chimique définie, exempt de sérum
HK1183057A1 (en) Cell culture insert
GB2489640B (en) Thin electrochemical cell
SG10201601434RA (en) Cell Culture System
GB201000375D0 (en) T Cell clonotypes
GB201017019D0 (en) Cell selection
HK1171790A1 (zh) 用於 蛋白表達的細胞培養基
EP2627762A4 (fr) Dispositif de culture cellulaire
EP3144319B8 (fr) Composition de culture cellulaire comprenant laminine-521
GB201017421D0 (en) Cell
PL2480655T3 (pl) Podłoże do hodowli komórkowych
GB201011667D0 (en) Cell culture vessel support
PL393251A1 (pl) Mikroukład do hodowli komórkowej
GB201016327D0 (en) Mammalian cell preservation methods
GB201000999D0 (en) Mammalian cell preservation methods
GB0915268D0 (en) Cell culture
GB0922428D0 (en) Cell culture
EP2598166A4 (fr) Cellules dépourvues de cmh
GB201007863D0 (en) Bioreactor for cell culture
GB201020580D0 (en) Cells
GB201019304D0 (en) Cells